StemGenex™ on Adult Stem Cell-Based Therapy for Multiple Sclerosis
StemGenex™ discusses the prospective use of autologous adipose-derived adult stem cells for relief of MS symptoms.
LA JOLLA, Calif., Oct. 10, 2012 /PRNewswire/ -- New research directions are being explored to find therapies for hard to treat diseases. One exciting new approach is the use of autologous Adult Stem Cells. Multiple Sclerosis (MS) is one of the many notable diseases adult stem cell therapy could potentially impact. Multiple Sclerosis (MS) is a disorder in which an individual's own immune system attacks the 'myelin sheath'. The myelin sheath serves to protect the nerve cells within the body's central nervous system (CNS). The damage caused by MS may result in many types of symptoms including:
- Muscle Control Problems
- Speech Problems
- Vision Loss
Currently there is no cure for MS, but MS stem cell therapies attempt to slow the disease's progression and limit symptoms. Since adult stem cells have the ability to differentiate into many different types of cells, such as those required for proper functioning and protection of nerve cells, the use of adult stem cells for MS therapy could be of substantial value. Adult stem cells can be isolated with relative ease from an individual's own 'adipose' (fat) tissue. As a result, adult stem cell therapy is not subject to the ethical or religious issues troubling embryonic methods.
Encouragingly for MS treatment potential, scientific researchers have been studying the properties of adipose-derived stem cells. Their results from canine and equine studies suggest anti-inflammatory and regenerative roles for these stem cells. Also, further research findings suggest these adipose-derived stem cells can have specific immune-regulating properties. Markedly, clinical-based work conducted overseas has indicated that individuals suffering from MS could respond well to adipose-derived stem cell treatment, with a substantially improved quality of life.
The US based company, StemGenex™, is pioneering new methods for using adipose derived adult stem cells to help in diseases with limited treatment options like MS. StemGenex™ has been conducting research with physicians over the last 5 years to advance adult stem cell treatment protocols for alleviating MS symptoms. StemGenex's proprietary protocol includes the use of a double activation process, which increases both the viability and the quantity of stem cells that are received in a single application.
To find out more about stem cell treatments contact StemGenex either by phone at 800.609.7795 or email at Contact@StemGenex.com.
More by this Source
StemGenex® Positions Itself Among Best Stem Cell Centers in U.S.
Apr 01, 2014, 09:00 ET
Mark Kalina, MD, Named Medical Director at StemGenex
Mar 25, 2014, 09:00 ET
Jeremiah McDole, Ph.D. Named Director of Clinical Research and Development at StemGenex®
Mar 18, 2014, 12:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.